(Q51919357)

English

Dosing and timing effects of anti-CD40L therapy: predictions from a mathematical model of type 1 diabetes.

scientific article published on 21 March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17376835

Dosing and timing effects of anti-CD40L therapy: predictions from a mathematical model of type 1 diabetes. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17376835

type-1 diabetes

0 references

mathematical model

1 reference

based on heuristic

inferred from title

author name string

Kapil G Gadkar

1

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17376835

Lisl K M Shoda

2

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17376835

Huub T C Kreuwel

3

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17376835

Saroja Ramanujan

4

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17376835

Yanan Zheng

5

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17376835

Chan C Whiting

6

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17376835

Daniel L Young

7

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17376835

language of work or name

0 references

publication date

21 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17376835

Annals of the New York Academy of Sciences

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17376835

1103

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17376835

63-68

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17376835

Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.013

21 January 2018

NOD mice have a generalized defect in their response to transplantation tolerance induction.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.013

21 January 2018

Peripheral CD4loCD40+ auto-aggressive T cell expansion during insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.013

21 January 2018

A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.013

21 January 2018

Identifiers

10.1196/ANNALS.1394.013

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17376835

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17376835

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51919357&oldid=1784064170"